FDA.reportPublic FDA data

0.9 ML triamcinolone acetonide 40 MG/ML Injection

RxCUI
2585221
RxNorm name
0.9 ML triamcinolone acetonide 40 MG/ML Injection
Display name
0.9 ML triamcinolone acetonide 40 MG/ML Injection
Full name
0.9 ML triamcinolone acetonide 40 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XipereTRIAMCINOLONE ACETONIDEBausch & Lomb Incorporatedea6ad429-967f-4f75-a33d-e06f849bee802025-10-08Warnings, Adverse reactionsExact identifier
rxcui: 2585221

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ea6ad429-967f-4f75-a33d-e06f849bee80triamcinolone acetonide 40 MG in 0.9 ML Injection [PSN] · 0.9 ML triamcinolone acetonide 40 MG/ML Injection [SCD] · triamcinolone acetonide 40 MG per 0.9 ML Injection [SY]37These highlights do not include all the information needed to use XIPERE ® safely and effectively. See full prescribing information for XIPERE ® . XIPERE ® (triamcinolone acetonide injectable suspension), for suprachoroidal use Initial U.S. Approval: 195720251008